Search
Emergent BioSolutions Inc
EBSAdd to Watchlist
8.000USD
-0.160-1.97%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
412.77MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
By RegionUSD
Name
Revenue
Proportion
Non-U.S Government
403.20M
54.27%
U.S.Government
36.70M
4.94%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Commercial Product sales
223.30M
30.06%
MCM Product sales
156.50M
21.07%
Contracts and grants
36.70M
4.94%
Bioservices
23.40M
3.15%
